Project Grant HT94252510200
Award Date
7/1/25
Completion Date
6/30/28
Dollars Obligated
$2M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21218, USA
Similar Awards
The Johns Hopkins University was awarded a $1,228,125 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will support research titled "PSMA-TARGETED ACTIVATED MYELOID CELLS AS A NOVEL PROSTATE CANCER IMMUNOTHERAPY" from September 2021 through September 2024. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical...
This $1,473,751 federal Project Grant award, issued on August 15, 2024 by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420), supports research by The Johns Hopkins University to investigate the influence of the tumor immune microenvironment and microbiome on prostate cancer immunotherapy response in Black men. The 3-year research initiative aims to transform healthcare through innovative and impactful medical research focused...
This $867,712 Project Grant award from the Department of the Army Medical Command (under the Military Medical Research and Development program, CFDA 12.420) supports advanced biomedical research at The Johns Hopkins University focused on transforming healthcare for military service members and the general public. The research aims to investigate effective treatment of pancreatic cancer through systemic chemotherapy combined with alpha-particle radiotherapy, with a focus on early hepatic...
The Department of the Army Medical Command awarded Duke University a $472,184 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 1, 2022 to August 31, 2024 to exploit ferropotosis for the treatment of RB1-deficient lethal prostate cancer. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health care...
The Johns Hopkins University was awarded a $1,397,591 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will support the development of a microfluidic assay to assess clinical utility for prognosis and precision medicine in breast cancer from May 1, 2022 to April 30, 2025. The Military Medical Research and Development program aims to transform military and public health through innovative...
The Department of the Army Medical Command awarded a $1.03 million Project Grant to The Johns Hopkins University under the Military Medical Research and Development program (CFDA 12.420) for the period of July 1, 2022 to June 30, 2025. The grant supports the integration of germline and somatic immunogenomic analyses to investigate African American prostate cancer. Specifically, the university will conduct basic, applied, and advanced biomedical research to transform military and public health...
The Johns Hopkins University was awarded a $982,500 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research from July 1, 2022 to June 30, 2025 to target glycoprotein nonmetastatic melanoma protein B (GPNMB) in renal tumors associated with tuberous sclerosis complex and translocation renal cell carcinoma. The Military Medical Research and Development program aims to transform military and public health...
The Johns Hopkins University will provide research services totaling $1,216,646 under a Project Grant award from the Defense Health Agency. The award's stated purpose is to investigate the role of polyamine metabolism in advanced prostate cancer. The grant falls under the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to transform military and public health care. Specifically, the program aims to develop medical solutions for battlefield...
The Department of the Army Medical Command awarded a $319,938 project grant under the Military Medical Research and Development (CFDA 12.420) program to The Johns Hopkins University. The grant, with a performance period from September 1, 2024 to August 31, 2026, will fund a large-scale MRI-based study to determine multiple sclerosis-specific atrophy phenotypes. This research aims to transform healthcare for military service members and the broader public by advancing the understanding and...
The Johns Hopkins University will utilize $1.473 million from the Defense Health Agency under the Military Medical Research and Development program to conduct the "UTILIZING B7-H3 TARGETED THERAPEUTICS TO PREVENT LETHAL PROSTATE CANCER: THE HELP ELUCIDATE & ATTACK LONGITUDINALLY (HEAL) PROSTATE CANCER TRIAL COHORT" project from July 2023 to June 2026. The University will perform research to develop targeted therapeutics aimed at preventing lethal prostate cancer through the HEAL...